INmune Bio Inc
NASDAQ:INMB 3:59:52 PM EDT
| Market Cap (Intraday) | 324.74M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $18.49 |
| 50-Day MA | $19.29 |
| 200-Day MA | $17.03 |
INmune Bio Inc Stock, NASDAQ:INMB
1200 Prospect Street, Suite 525, La Jolla, California 92037
United States of America
Phone: +1.858.964.3720
Number of Employees: 5
Description
INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer�s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.